IBM (IBM) Offering Possible 20.05% Return Over the Next 28 Calendar Days

IBM's most recent trend suggests a bearish bias. One trading opportunity on IBM is a Bear Call Spread using a strike $120.00 short call and a strike $130.00 long call offers a potential 20.05% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $120.00 by expiration. The full premium credit of $1.67 would be kept by the premium seller. The risk of $8.33 would be incurred if the stock rose above the $130.00 long call strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for IBM is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for IBM is bearish.

The RSI indicator is at 30.07 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for IBM

Qualcomm CEO: It's our moment to be ‘recognized'
Wed, 17 Nov 2021 17:41:16 +0000
Qualcomm's stock just hit a record. Here's what the company's CEO thinks about it.

IBM and David Clark Cause Crown Saaf Water Winner of 4th Annual Call for Code Global Challenge
Wed, 17 Nov 2021 01:30:00 +0000
Today, Call for Code founding partner IBM (NYSE: IBM) and its creator, David Clark Cause, announced the winner of the fourth annual Call for Code Global Challenge, which invited innovators across the globe to combat climate change with open source-powered technology. Call for Code is the largest and most ambitious effort to bring together the world's software developers to take on pressing societal issues by using the latest advanced technologies to problem solve and create cutting-edge solution

Fortune and IBM Watson Health Reveal Annual List of 50 Top-Performing U.S. Cardiovascular Hospitals
Tue, 16 Nov 2021 12:00:00 +0000
IBM (NYSE: IBM) Watson Health today announced its 2022 Fortune/IBM Watson Health 50 Top Cardiovascular Hospitals list, naming the top-performing U.S. hospitals for inpatient cardiovascular services. This year's study included 951 U.S. hospitals with cardiovascular service lines. Based on comparisons between the study winners and a peer group of similar hospitals in the study, the winners delivered better outcomes while operating more efficiently and at a lower cost. The list of the top cardiovas

IBM Unveils Breakthrough 127-Qubit Quantum Processor
Tue, 16 Nov 2021 11:00:00 +0000
IBM (NYSE: IBM) today announced its new 127-quantum bit (qubit) ‘Eagle' processor at the IBM Quantum Summit 2021, its annual event to showcase milestones in quantum hardware, software, and the growth of the quantum ecosystem. The ‘Eagle' processor is a breakthrough in tapping into the massive computing potential of devices based on quantum physics. It heralds the point in hardware development where quantum circuits cannot be reliably simulated exactly on a classical computer. IBM also previewed

IBM claims it has made a quantum chip that cannot be simulated by classical computers in major breakthrough
Mon, 15 Nov 2021 17:37:36 +0000
IBM says it has built a quantum processor that it says cannot be simulated by a classical computer. If true, the processor would represent a major breakthrough in quantum computing, which its proponents say could lead to radical changes in how we are able to deal with information. The company says that the quantum processor is so capable that to simulate its capabilities with a traditional computer, one would require more bits than there are atoms in every person in existence.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.